Back to Ingredient Dictionary

Common Name(s): Neoruscogenin,neoruscogenin,ruscus spirostanol saponin aglycone,anti-oedema vascular active

CAS Number: N/a

DESCRIPTION

What It Does: Provides vascular smooth muscle contraction through alpha-1 adrenergic receptor agonism to reduce periorbital puffiness and leg oedema, inhibits hyaluronidase protecting capillary basement membrane integrity, and modulates nf-kb for anti-inflammatory support.

Why It's Used: Neoruscogenin's alpha-1 adrenergic agonism provides the most physiologically direct anti-oedema mechanism โ€” activating the same receptor as endogenous norepinephrine for vein smooth muscle contraction that reduces the venous pooling causing periorbital puffiness and leg heaviness.

How It Works: Neoruscogenin spirostanol ring: alpha-1 adrenergic receptor partial agonism (kd ~500 nm) โ†’ gq-plc โ†’ ip3 โ†’ caยฒโบ โ†’ vein smooth muscle contraction โ†’ reduced venous pooling โ†’ decreased oedema. hyaluronidase inhibition (ic50 ~50 ฮผm): saponin competitive inhibition protecting vascular basement membrane ha from enzymatic degradation.

Typically Found In: Anti-puffiness,vascular skin care,leg care

TECHNICAL DETAILS

Primary Category: Active ingredient โ€“ antioxidant

Secondary Functions: Free radical scavenging,anti-aging

Application Areas:

Facial Skincare

Body Care

Hair Care

Beard Care

Color Cosmetics (Makeup)

Dietary/Oral Supplements

Typical Concentration Range: 0.01%โ€“1%

SOURCING & ETHICS

Vegan Status: Yes

Halal Status: Yes

Source Notes: Plant-derived extract or synthetic.

SKIN COMPATIBILITY

Irritancy Rating: 1/5 โ€“ very low

Comedogenicity Rating: 0/5 โ€“ non-comedogenic

Sensitivity Concerns: Non-irritating; well-tolerated.

Safe for Sensitive Skin: Yes

SAFETY & COMPATIBILITY

Safety Profile: Excellent safety profile. ewg score: 1.

Works Well With: Vitamin c,vitamin e,ferulic acid,spf,other antioxidants

Avoid Combining With: No significant incompatibilities

SCIENTIFIC NOTE

Butcher's broom pharmaceutical use: ruscus aculeatus extract (standardised to ruscogenins) is approved as a medicine for chronic venous insufficiency in several eu markets โ€” the same vascular pharmacology applicable to cosmetic anti-oedema and anti-puffiness claims at cosmetic concentrations.

Last Verified: 2026-03-22

Primary Sources: Cosing database,neoruscogenin ruscus alpha-1 adrenergic anti-oedema review